Scilex issues warrant to Oramed for 100,000 shares at $20.00 in exchange for payment deferral

Scilex Holding Co

Warrant for 100,000 shares at $20.00 issued to Oramed Pharmaceuticals for deferring an amortization payment originally due Oct 1, 2025.
Deferred payment was made in November 2025; warrant is immediately exercisable and expires Dec 13, 2029.
Exercise price subject to anti-dilution adjustments with a floor of $8.22; beneficial ownership limit set at 4.99%.
Company commits to file a resale registration statement for the underlying shares within 30 days or by March 31, 2026.
Warrant agreement includes most-favored-nations clause for six months and standard change-of-control repurchase right.

item 1.01 item 3.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

Scilex Holding Co entered into Warrant Agreement with Oramed Pharmaceuticals Inc. (effective 2026-02-19).

Action: entry
Counterparty: Oramed Pharmaceuticals Inc.
Effective: 2026-02-19

Exact text from the filing

On February 19, 2026, Scilex Holding Company (the “ Company ”) entered into a Warrant Agreement (the “ Warrant Agreement ”) with Oramed Pharmaceuticals Inc. (“ Oramed ”).

View on SEC.gov

314 material agreements filed in the last 30 days. Browse all material agreements →

Scilex Holding Co filing history →

Source: SEC EDGAR

accession 0001193125-26-061371

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.